
Rei Tsang Shiao
Examiner (ID: 13461)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1626, 1628, 1629, 1691 |
| Total Applications | 3000 |
| Issued Applications | 2172 |
| Pending Applications | 215 |
| Abandoned Applications | 676 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4812943
[patent_doc_number] => 20080193574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Inhibitors Of Cognitive Decline'
[patent_app_type] => utility
[patent_app_number] => 11/863549
[patent_app_country] => US
[patent_app_date] => 2007-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7854
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193574.pdf
[firstpage_image] =>[orig_patent_app_number] => 11863549
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/863549 | Inhibitors of cognitive decline | Sep 27, 2007 | Issued |
Array
(
[id] => 4675588
[patent_doc_number] => 20080213217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Enantiomerically pure phosphoindoles as HIV inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/906095
[patent_app_country] => US
[patent_app_date] => 2007-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 59543
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213217.pdf
[firstpage_image] =>[orig_patent_app_number] => 11906095
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/906095 | Enantiomerically pure phosphoindoles as HIV inhibitors | Sep 27, 2007 | Issued |
Array
(
[id] => 6499150
[patent_doc_number] => 20100286198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Biofilm-Inhibiting Effect and Anti-Infective Activity of N,C- Linked Arylisoquinolines and the Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/443318
[patent_app_country] => US
[patent_app_date] => 2007-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7304
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286198.pdf
[firstpage_image] =>[orig_patent_app_number] => 12443318
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/443318 | Biofilm-inhibiting effect and anti-infective activity of N,C-linked aryl isoquinolines and the use thereof | Sep 26, 2007 | Issued |
Array
(
[id] => 6402340
[patent_doc_number] => 20100305142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => '3-AMINOIMIDAZO 1,2-A PYRIDINE DERIVATIVES HAVING AN SGLT1- AND SGLT2-INHIBITING ACTION FOR THE TREATMENT OF TYPE 1 AND TYPE 2 DIABETES'
[patent_app_type] => utility
[patent_app_number] => 12/445661
[patent_app_country] => US
[patent_app_date] => 2007-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12670
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20100305142.pdf
[firstpage_image] =>[orig_patent_app_number] => 12445661
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/445661 | 3-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the treatment of type 1 and type 2 diabetes | Sep 26, 2007 | Issued |
Array
(
[id] => 8340180
[patent_doc_number] => 08242105
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-14
[patent_title] => 'Structural mimetics of proline-rich peptides and the pharmaceutical use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/442681
[patent_app_country] => US
[patent_app_date] => 2007-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 31096
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12442681
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/442681 | Structural mimetics of proline-rich peptides and the pharmaceutical use thereof | Sep 24, 2007 | Issued |
Array
(
[id] => 44611
[patent_doc_number] => 07777068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-17
[patent_title] => 'Ni(0) -containing catalyst system'
[patent_app_type] => utility
[patent_app_number] => 11/860972
[patent_app_country] => US
[patent_app_date] => 2007-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9216
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/777/07777068.pdf
[firstpage_image] =>[orig_patent_app_number] => 11860972
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/860972 | Ni(0) -containing catalyst system | Sep 24, 2007 | Issued |
Array
(
[id] => 4445445
[patent_doc_number] => 07863456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-04
[patent_title] => 'Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-YL]-benzoic acid'
[patent_app_type] => utility
[patent_app_number] => 11/904005
[patent_app_country] => US
[patent_app_date] => 2007-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12608
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/863/07863456.pdf
[firstpage_image] =>[orig_patent_app_number] => 11904005
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/904005 | Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-YL]-benzoic acid | Sep 23, 2007 | Issued |
Array
(
[id] => 6149878
[patent_doc_number] => 20110021473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'INHIBITORS OF PHOSPHODIESTERASE TYPE-IV'
[patent_app_type] => utility
[patent_app_number] => 12/442257
[patent_app_country] => US
[patent_app_date] => 2007-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22556
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021473.pdf
[firstpage_image] =>[orig_patent_app_number] => 12442257
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/442257 | INHIBITORS OF PHOSPHODIESTERASE TYPE-IV | Sep 21, 2007 | Abandoned |
Array
(
[id] => 4927907
[patent_doc_number] => 20080167270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'ANTI-INFECTIVE PHOSPHONATE ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 11/858812
[patent_app_country] => US
[patent_app_date] => 2007-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 162158
[patent_no_of_claims] => 98
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20080167270.pdf
[firstpage_image] =>[orig_patent_app_number] => 11858812
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/858812 | ANTI-INFECTIVE PHOSPHONATE ANALOGS | Sep 19, 2007 | Abandoned |
Array
(
[id] => 4966024
[patent_doc_number] => 20080108844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Non Hydroquinone Cyanoacrylate Cracking Process'
[patent_app_type] => utility
[patent_app_number] => 11/854639
[patent_app_country] => US
[patent_app_date] => 2007-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2057
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108844.pdf
[firstpage_image] =>[orig_patent_app_number] => 11854639
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/854639 | Non Hydroquinone Cyanoacrylate Cracking Process | Sep 12, 2007 | Abandoned |
Array
(
[id] => 4928113
[patent_doc_number] => 20080167476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'Process for the preparation of 2-substituted-7-Boryl indoles and compounds'
[patent_app_type] => utility
[patent_app_number] => 11/900272
[patent_app_country] => US
[patent_app_date] => 2007-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11318
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20080167476.pdf
[firstpage_image] =>[orig_patent_app_number] => 11900272
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/900272 | Process for the preparation of 2-substituted-7-Boryl indoles and compounds | Sep 10, 2007 | Abandoned |
Array
(
[id] => 4867755
[patent_doc_number] => 20080146814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Process for producing N-protected boryl compounds'
[patent_app_type] => utility
[patent_app_number] => 11/900303
[patent_app_country] => US
[patent_app_date] => 2007-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13921
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20080146814.pdf
[firstpage_image] =>[orig_patent_app_number] => 11900303
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/900303 | Process for producing N-protected boryl compounds | Sep 10, 2007 | Abandoned |
Array
(
[id] => 5398434
[patent_doc_number] => 20090318497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'SUBSTITUTED PYRIDYLMETHYL BICYCLICCARBOXYAMIDE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/439888
[patent_app_country] => US
[patent_app_date] => 2007-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23169
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318497.pdf
[firstpage_image] =>[orig_patent_app_number] => 12439888
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/439888 | Substituted pyridylmethyl bicycliccarboxyamide compounds | Sep 9, 2007 | Issued |
Array
(
[id] => 5558934
[patent_doc_number] => 20090270511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'PRODRUGS OF INHIBITORS OF CATHEPSIN S'
[patent_app_type] => utility
[patent_app_number] => 12/439323
[patent_app_country] => US
[patent_app_date] => 2007-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9198
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20090270511.pdf
[firstpage_image] =>[orig_patent_app_number] => 12439323
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/439323 | PRODRUGS OF INHIBITORS OF CATHEPSIN S | Sep 6, 2007 | Abandoned |
Array
(
[id] => 5304159
[patent_doc_number] => 20090298811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'BENZIMIDAZOLONE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/440646
[patent_app_country] => US
[patent_app_date] => 2007-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72726
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298811.pdf
[firstpage_image] =>[orig_patent_app_number] => 12440646
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/440646 | BENZIMIDAZOLONE DERIVATIVES | Sep 2, 2007 | Abandoned |
Array
(
[id] => 4772674
[patent_doc_number] => 20080058333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'CYCLOALKYL KETOAMIDES DERIVATIVES USEFUL AS CATHEPSIN K INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 11/848290
[patent_app_country] => US
[patent_app_date] => 2007-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36594
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20080058333.pdf
[firstpage_image] =>[orig_patent_app_number] => 11848290
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/848290 | CYCLOALKYL KETOAMIDES DERIVATIVES USEFUL AS CATHEPSIN K INHIBITORS | Aug 30, 2007 | Abandoned |
Array
(
[id] => 7550905
[patent_doc_number] => 08063238
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-22
[patent_title] => 'Diamine compound having phosphorylcholine group, polymer thereof, and process for producing the polymer'
[patent_app_type] => utility
[patent_app_number] => 12/439192
[patent_app_country] => US
[patent_app_date] => 2007-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12821
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/063/08063238.pdf
[firstpage_image] =>[orig_patent_app_number] => 12439192
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/439192 | Diamine compound having phosphorylcholine group, polymer thereof, and process for producing the polymer | Aug 30, 2007 | Issued |
Array
(
[id] => 4677218
[patent_doc_number] => 20080214849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS'
[patent_app_type] => utility
[patent_app_number] => 11/847118
[patent_app_country] => US
[patent_app_date] => 2007-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48508
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214849.pdf
[firstpage_image] =>[orig_patent_app_number] => 11847118
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/847118 | Phospholipids with unsaturated alkyl and acyl chains | Aug 28, 2007 | Issued |
Array
(
[id] => 4922776
[patent_doc_number] => 20080071093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'BORON COMPLEXATION STRATEGY FOR USE IN MANIPULATING 1-ACYLDIPYRROMETHANES'
[patent_app_type] => utility
[patent_app_number] => 11/846646
[patent_app_country] => US
[patent_app_date] => 2007-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 24591
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20080071093.pdf
[firstpage_image] =>[orig_patent_app_number] => 11846646
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/846646 | Boron complexation strategy for use in manipulating 1-acyldipyrromethanes | Aug 28, 2007 | Issued |
Array
(
[id] => 6257172
[patent_doc_number] => 20100029617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => '1,4,5,6,7,8-HEXAHYDRO-1,2,5-TRIAZA-AZULENE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/439303
[patent_app_country] => US
[patent_app_date] => 2007-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10780
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029617.pdf
[firstpage_image] =>[orig_patent_app_number] => 12439303
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/439303 | 1,4,5,6,7,8-HEXAHYDRO-1,2,5-TRIAZA-AZULENE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS | Aug 26, 2007 | Abandoned |